Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Prospective and Retrospective Follow-up of Patients With COVID-19 Infected Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenström Disease

NCT04391946 is registered in ClinicalTrials.gov with French Innovative Leukemia Organisation as lead sponsor.

NCT NCT04391946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Prospective and Retrospective Follow-up of Patients With COVID-19 Infected Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenström Disease
Lead sponsor
French Innovative Leukemia Organisation
Phase
Observational
Overall status
Completed
Start date
March 14, 2020
Completion date
March 10, 2023
Enrollment
162 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, lymphocytic lymphoma or waldenstrom disease